Statistical Methods in Medical Research, p.131, 1994. ,
Executive functions in multiple sclerosis: An analysis of temporal ordering, semantic encoding, and planning abilities., Neuropsychology, vol.11, issue.4, pp.535-544, 1997. ,
DOI : 10.1037/0894-4105.11.4.535
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, issue.11, pp.2059-2069, 1997. ,
DOI : 10.1093/brain/120.11.2059
Mood and Memory Changes in Asthmatic Children Receiving Corticosteroids, Journal of the American Academy of Child & Adolescent Psychiatry, vol.27, issue.6, pp.720-725, 1988. ,
DOI : 10.1097/00004583-198811000-00010
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS), Journal of the International Neuropsychological Society, vol.41, issue.04, pp.549-558, 2006. ,
DOI : 10.1002/ana.1032
Sertraline Treatment of Mood Disorder Associated with Prednisone: A Case Report, Journal of Child and Adolescent Psychopharmacology, vol.8, issue.3, pp.187-93, 1998. ,
DOI : 10.1089/cap.1998.8.187
SUICIDE FOLLOWING CORTISONE TREATMENT, Journal of the American Medical Association, vol.146, issue.4, pp.337-338, 1951. ,
DOI : 10.1001/jama.1951.63670040004007b
The psychiatric side effects of corticosteroids, Annals of Allergy, Asthma & Immunology, vol.83, issue.6, 1999. ,
DOI : 10.1016/S1081-1206(10)62858-X
Mood Changes During Prednisone Bursts in Outpatients With Asthma, Journal of Clinical Psychopharmacology, vol.22, issue.1, pp.55-61, 2002. ,
DOI : 10.1097/00004714-200202000-00009
An open-label trial of olanzapine for corticosteroid-induced mood symptoms, Journal of Affective Disorders, vol.83, issue.2-3, pp.277-285, 2004. ,
DOI : 10.1016/j.jad.2004.07.001
Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy, Biological Psychiatry, vol.57, issue.5, pp.543-548, 2005. ,
DOI : 10.1016/j.biopsych.2004.11.021
Effect of two prednisone exposures on mood and declarative memory, Neurobiology of Learning and Memory, vol.86, issue.1, pp.28-34, 2006. ,
DOI : 10.1016/j.nlm.2005.12.009
Effects of chronic prednisone therapy on mood and memory, Journal of Affective Disorders, vol.99, issue.1-3, pp.1-3, 2007. ,
DOI : 10.1016/j.jad.2006.09.004
Effects of Glucocorticoids on Mood, Memory, and the Hippocampus, Annals of the New York Academy of Sciences, vol.10, issue.1, 2009. ,
DOI : 10.1016/S0033-3182(93)71910-6
Suicide among Danes with multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.10, pp.1457-1466, 2005. ,
DOI : 10.1136/jnnp.2004.056747
Possibility of Biochemical Test for Suicidal Potential. An Analysis of Endocrine Findings Prior to Three Suicides, The JAMA Network, 1965. ,
Bio-chemical research in dépression and suicide in suicidal behavior : Diagnosis and Management, 1968. ,
Olanzapine for Corticosteroid-Induced Mood Disorders, Psychosomatics, vol.44, issue.4, p.353, 2003. ,
DOI : 10.1176/appi.psy.44.4.353
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis, Cochrane Databse . Syst Rev, 2012. ,
Delirium after cessation of glucocorticoid therapy, General Hospital Psychiatry, vol.13, issue.4, pp.270-272, 1991. ,
DOI : 10.1016/0163-8343(91)90129-K
The risk of Bipolar Disorders in Multiple Sclerosis Trincas, E ,
Corticotherapy and suicidal behavior: A case report, Encephale, p.2016 ,
URL : https://hal.archives-ouvertes.fr/hal-01288213
High-and low-dose prednisolone for Transplant, Proc, vol.13, pp.336-338, 1981. ,
Psychiatric Issues in Multiple Sclerosis, Psychiatric Clinics of North America, vol.30, issue.4, pp.803-817, 2007. ,
DOI : 10.1016/j.psc.2007.07.003
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2706287
COURSE AND PROGNOSIS OF MULTIPLE SCLEROSIS ASSESSED BY THE COMPUTERIZED DATA PROCESSING OF 349 PATIENTS, Brain, vol.103, issue.2, pp.281-300, 1980. ,
DOI : 10.1093/brain/103.2.281
Relapses and progression of disability in multiple sclerosis. New Engl, J. Med, vol.343, issue.20, pp.1430-1438, 2000. ,
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, Brain, vol.126, issue.4, pp.770-782, 2003. ,
DOI : 10.1093/brain/awg081
Corticoids Dosing for Flares in Relapsing Remitting Multiple Sclerosis, 2017. ,
The Effect of Telephone-Administered Cognitive???Behavioral Therapy on Quality of Life among Patients with Multiple Sclerosis, Annals of Behavioral Medicine, vol.56, issue.5, pp.227-261, 2011. ,
DOI : 10.1037/0003-066X.56.3.218
Disease activity and emotional state in multiple sclerosis, Annals of Neurology, vol.8, issue.5, pp.573-580, 1983. ,
DOI : 10.1001/archneurpsyc.1922.02190130062009
Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Tr??ndelag County, Norway, Multiple Sclerosis Journal, vol.65, issue.12, pp.1495-501, 2009. ,
DOI : 10.1191/1352458503ms927oa
Steroid-Induced Psychosis Treated with Risperidone, The Canadian Journal of Psychiatry, vol.9, issue.4, pp.388-389, 2002. ,
DOI : 10.1089/cap.1999.9.315
Lithium Prophylaxis of Corticotropin-lnduced Psychosis, JAMA: The Journal of the American Medical Association, vol.241, issue.10, pp.1011-1013, 1979. ,
DOI : 10.1001/jama.1979.03290360027021
Perception par les me decins internistes de la fre quence et de la ge ne induite par les effets inde sirables d'une corticothe rapie syste mique prolonge e, 2008. ,
Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care, American Journal of Psychiatry, vol.169, issue.5, pp.491-497, 2012. ,
DOI : 10.1176/appi.ajp.2011.11071009
An examination of suicidal intent in patients with multiple sclerosis, Neurology, vol.59, issue.5, pp.674-682, 2002. ,
DOI : 10.1212/WNL.59.5.674
Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex1999, pp.69-73 ,
A Happy State of Mind, Archives of Neurology, vol.55, issue.2, pp.241-50, 1998. ,
DOI : 10.1001/archneur.55.2.241
Steroid-induced psychosis complicating orthognathic surgery: A case report, British Dental Journal, vol.42, issue.10, pp.647-648, 2005. ,
DOI : 10.1016/S0266-4356(03)00192-X
URL : http://www.nature.com/bdj/journal/v199/n10/pdf/4812929a.pdf
Cognitive Loss in Multiple Sclerosis, Archives of Neurology, vol.46, issue.2, pp.162-167, 1989. ,
DOI : 10.1001/archneur.1989.00520380066014
Affective temperaments in the bipolar and unipolar disorders: distinctive profiles and relationship with clinical features, pp.477-525, 2008. ,
Disabil Rehabil. Suicidal thinking in multiple sclerosis, pp.17-181528, 2011. ,
Depression, somatization and steroid use in chronic obstructive pulmonary disease, International Journal of Nursing Studies, vol.26, issue.3, pp.281-287, 1989. ,
DOI : 10.1016/0020-7489(89)90009-6
Gilad VH Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress, pp.2401-2409, 1987. ,
Olanzapine Treatment of Corticosteroid-Induced Mood Disorders, Psychosomatics, vol.43, issue.6, pp.495-497, 2002. ,
DOI : 10.1176/appi.psy.43.6.495
Presentation of the Steroid Psychoses, The Journal of Nervous and Mental Disease, vol.167, issue.4, pp.229-236, 1979. ,
DOI : 10.1097/00005053-197904000-00006
Sex and gender issues in multiple sclerosis, Ther Adv Neurol Disrder, vol.6, issue.4, pp.237-248, 2013. ,
Diagnostic categorization of psychiatric disturbance in Cushing's syndrome, American Journal ofPsychiatry, vol.142, pp.911-916, 1985. ,
Prednisolone-21-stearoylglycolate in scleritis., British Journal of Ophthalmology, vol.54, issue.6, pp.394-398, 1970. ,
DOI : 10.1136/bjo.54.6.394
URL : http://bjo.bmj.com/content/bjophthalmol/54/6/394.full.pdf
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study, Journal of Neurology, Neurosurgery & Psychiatry, vol.33, issue.10, pp.1109-1124, 2014. ,
DOI : 10.1002/hbm.21279
URL : http://jnnp.bmj.com/content/jnnp/85/10/1109.full.pdf
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register, PLoS ONE, vol.7, issue.7, pp.41910-41920, 2012. ,
DOI : 10.1371/journal.pone.0041910.s001
Anxiety disorders and their clinical correlates in multiples sclrosis, 2007. ,
Brain Association between C-reactive protein (CRP) with depression symptom severity and speci fic depressive symptoms in major depression.Behav Immun, pp.889-159130062, 2017. ,
Origin of Fatigue in Multiple Sclerosis: Review of the Literature, Neurorehabilitation and Neural Repair, vol.21, issue.11, 2008. ,
DOI : 10.1002/(SICI)1097-4598(199808)21:8<1068::AID-MUS12>3.0.CO;2-Q
Familial Comorbidity of Bipolar Disorder and Multiple Sclerosis: Genetic Susceptibility, Coexistence or Causal Relationship?, Behavioural Neurology, vol.25, issue.4, pp.341-350, 2012. ,
DOI : 10.1155/2012/894128
URL : http://doi.org/10.1155/2012/894128
Risperidone in the Treatment of Steroid-Induced Psychosis, Journal of Child and Adolescent Psychopharmacology, vol.9, issue.4, pp.315-316, 1999. ,
DOI : 10.1089/cap.1999.9.315
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-1452, 1983. ,
DOI : 10.1212/WNL.33.11.1444
Neuropsychiatric considerations in the use of electroconvulsive therapy, J Neuropsychiatry Clin Neurosci, vol.9, pp.283-92, 1997. ,
Neuropsychiatric Manifestations of Multiple Sclerosis, The Primary Care Companion to The Journal of Clinical Psychiatry, vol.10, issue.04, pp.318-324, 2008. ,
DOI : 10.4088/PCC.v10n0408
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528238/pdf
Is it time for immuno-psychiatry in bipolar disorder and suicidal behaviour?, Acta Psychiatrica Scandinavica, vol.132, issue.3, pp.159-60, 2015. ,
DOI : 10.1111/acps.12433
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial, The Lancet, vol.386, issue.9997 ,
DOI : 10.1016/S0140-6736(15)61137-0
Effets psychologiques d???une administration de courte dur??e de prednisolone, Science & Sports, vol.23, issue.2, pp.91-93, 2008. ,
DOI : 10.1016/j.scispo.2007.10.013
Steroid-induced psychiatric syndromes, Journal of Affective Disorders, vol.5, issue.4, pp.319-332, 1983. ,
DOI : 10.1016/0165-0327(83)90022-8
Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects, Ph.D.Adverse Consequences of Glucocorticoid Medication:Psychological, Cognitive, and Behavioral Effects, pp.1045-1051, 2014. ,
DOI : 10.1176/appi.ajp.2014.13091264
Structural and functional features of central nervous system lymphatic vessels, Nature, vol.14, issue.7560, pp.337-378, 2015. ,
DOI : 10.1097/00019052-200106000-00006
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506234
Mortality in multiple sclerosis: metaanalysis of standardised mortality ratios, Neuropathology of stress, vol.12787, issue.13, pp.109-13324, 2014. ,
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, 2001. ,
The prevalence of cognitive impairment in a community survey of multiple sclerosis, British Journal of Clinical Psychology, vol.30, issue.4, pp.333-348, 1991. ,
DOI : 10.1111/j.2044-8260.1991.tb00954.x
Sytemic glucocorticoid therapy: rik factors for reported adverse events and beliefs about the drugs. A cross sectional online survey of 820 patients, pp.2119-2145, 2015. ,
Les anti-in flammatoires steroidiens, 2005. ,
The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis, Neurology, vol.63, issue.6, pp.1079-1080, 2004. ,
DOI : 10.1212/01.WNL.0000138572.82125.F5
Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses, Journal of Affective Disorders, vol.187, pp.142-148, 2015. ,
DOI : 10.1016/j.jad.2015.08.040
Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment: a prospective study. Psychoneuro-endocrinology, pp.25-31, 1996. ,
Corticosteroids regulate 5-HT1A but not 5-HT1B receptor mRNA in rat hippocampus, Molecular Brain Research, vol.82, issue.1-2, pp.65-73, 2000. ,
DOI : 10.1016/S0169-328X(00)00181-9
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847791/pdf
The Optic Neuritis Treatment Trial :A Definitive Answer and Profound Impact With Unexpected Results, Arch Ophthalmol, pp.996-1005, 2008. ,
Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus, Psychoneuroendocrinology, vol.33, issue.3, pp.395-403, 2008. ,
DOI : 10.1016/j.psyneuen.2007.12.007
Assessment of emotional problems in people with multiple sclerosis, Clinical Rehabilitation, vol.22, issue.6, pp.657-68, 2001. ,
DOI : 10.1023/A:1018731415172
Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata, Archives of Dermatology, vol.128, issue.11, pp.1467-1473, 1992. ,
DOI : 10.1001/archderm.1992.01680210045005
Major depression in multiple sclerosis: A population-based perspective, Neurology, vol.61, issue.11, pp.1524-1527, 2003. ,
DOI : 10.1212/01.WNL.0000095964.34294.B4
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.581.3646
Exogenous corticosteroids and major depression in the general population, Journal of Psychosomatic Research, vol.49, issue.6, pp.447-456, 2000. ,
DOI : 10.1016/S0022-3999(00)00187-2
Multiple sclerosis relapses and depression, Journal of Psychosomatic Research, vol.73, issue.4, pp.272-276, 2012. ,
DOI : 10.1016/j.jpsychores.2012.08.004
Corticotherapy in emergency department: an update, Re animation, vol.15, pp.533-539, 2006. ,
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2010. ,
DOI : 10.1002/ana.21464
URL : http://onlinelibrary.wiley.com/doi/10.1002/ana.22366/pdf
Suicide risk in multiple sclerosis: A systematic review of current literature, Journal of Psychosomatic Research, vol.73, issue.6, 2012. ,
DOI : 10.1016/j.jpsychores.2012.09.011
Neuropsychiatric Manifestations of Multiple Sclerosis, Prim Care Companion J Clini psychiatry, vol.10, pp.318-324, 2008. ,
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, Annals of Neurology, vol.122, issue.3, pp.227-231, 1983. ,
DOI : 10.1212/WNL.29.9_Part_2.3
Exogenous corticosteroid effects on mood and cognition: case presentations, Int J Psychosom, vol.37, issue.1-4, pp.57-61, 1990. ,
Oral glucocorticoid-induced psychiatric side-effects: Focus on clinical speci ficities, incidence, risk factors and treatment. La Revue de Médecine Interne, pp.293-302, 2013. ,
THE PSYCHOLOGICAL RESPONSE TO ACTH, CORTISONE, HYDROCORTISONE, AND RELATED STEROID SUBSTANCES, American Journal of Psychiatry, vol.108, issue.9, 1952. ,
DOI : 10.1176/ajp.108.9.641
Glucocorticoi ds and hippocampal atrophy in neuropsychiatric disorders, Archives of General Psychiatry, vol.57, issue.10, pp.925-960, 2000. ,
Alessia Cozzolino Neuropsychiatric disorders in Cushing's syndrome, Front Neurosci, vol.9, p.129, 2015. ,
Cognitive impairment differs between primary progressive and relapsing-remitting MS, Neurology, vol.80, issue.16, pp.80-1501, 2013. ,
DOI : 10.1212/WNL.0b013e31828cf82f
Management of corticosteroid-induced psychosis with lithium, Clin Pharm, vol.6, issue.3, p.186, 1987. ,
Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses, Journal of Affective Disorders, vol.187, pp.142-143, 2015. ,
DOI : 10.1016/j.jad.2015.08.040
Modi fications neurocomportemetales secondaires à la sclérose en plaques, Rev Med Suisse, pp.951-954, 2009. ,
The Neuroendocrinology of Stress and Aging: The Glucocorticoid Cascade Hypothesis*, Endocrine Reviews, vol.7, issue.3, pp.284-301, 1986. ,
DOI : 10.1210/edrv-7-3-284
Longitudinal follow-up of "benign" multiple sclerosis at 20 years, Neurology, vol.68, issue.7, pp.496-500, 2007. ,
DOI : 10.1212/01.wnl.0000253185.03943.66
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS, Annals of the New York Academy of Sciences, vol.43, issue.6, pp.552-568, 1965. ,
DOI : 10.1001/archneurpsyc.1939.02270170051002
Quetiapine Therapy for Corticosteroid-Induced Mania, The Canadian Journal of Psychiatry, vol.76, issue.1, pp.77-85, 2005. ,
DOI : 10.1016/S0165-0327(02)00075-7
Steroid-induced psychosis, Journal of Oral and Maxillofacial Surgery, vol.53, issue.2, pp.183-186, 1995. ,
DOI : 10.1016/0278-2391(95)90398-4
Anxiety, depression and fatigue at 5-year review following CNS demyelination, Acta Neurologica Scandinavica, vol.49, issue.6, pp.403-413, 2016. ,
DOI : 10.1002/art.11405
Modi fications neurocomportemetales secondaires à la sclérose en plaques, Rev Med Suisse, pp.951-954, 2009. ,
Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive Episodes, JAMA Psychiatry, vol.72, issue.3, pp.268-75 ,
DOI : 10.1001/jamapsychiatry.2014.2427
Antidepressant pharmacotherapy of depression associated with multiple sclerosis, Am J Psychiatry, vol.147, pp.1493-1500, 1990. ,
Corticosteroid-induced psychiatric disturbances: It is time for pharmacists to take notice, Research in Social and Administrative Pharmacy, vol.12, issue.2, pp.355-360, 2016. ,
DOI : 10.1016/j.sapharm.2015.05.012
Perceived Behavioral Changes in Early Multiple Sclerosis, Behavioural Neurology, vol.18, issue.2, pp.81-90, 2007. ,
DOI : 10.1155/2007/674075
URL : http://doi.org/10.1155/2007/674075
Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels, 1981. ,
Multiple sclerosis: correlation of psychiatric admissions to onset of initial symptoms, Acta Neurologica Scandinavica, vol.16, issue.5, 1988. ,
DOI : 10.1212/WNL.21.12.1179
Secondary Mania with Steroid Withdrawal, The Canadian Journal of Psychiatry, vol.61, issue.280, pp.631-632, 1988. ,
DOI : 10.1159/000123142
Carbamazepine treatment of corticosteroid-induced mood disorder, Journal of Affective Disorders, vol.65, issue.3, pp.315-322, 2001. ,
DOI : 10.1016/S0165-0327(00)00249-4
Psychiatric Adverse Effects of Corticosteroids, Mayo Clinic Proceedings, vol.81, issue.10, pp.1361-1367, 2006. ,
DOI : 10.4065/81.10.1361
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS, Neurologic Clinics, vol.14, issue.2, pp.533-564, 1995. ,
DOI : 10.1016/S0733-8619(05)70257-7
Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids???, Psychoneuroendocrinology, vol.19, issue.3, pp.233-255, 1994. ,
DOI : 10.1016/0306-4530(94)90064-7
Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids???, Psychoneuroendocrinology, vol.19, issue.3, pp.233-255, 1978. ,
DOI : 10.1016/0306-4530(94)90064-7